Recent findings in the genetics and epigenetics of asthma and allergy

被引:0
作者
Michael Kabesch
Jörg Tost
机构
[1] University Children’s Hospital Regensburg (KUNO),Department of Pediatric Pneumology and Allergy, St. Hedwig’s Hospital of the order of St. John
[2] Laboratory for Epigenetics and Environment,undefined
[3] Centre National de Recherche en Génomique Humaine,undefined
[4] CEA - Institut de Biologie François Jacob,undefined
来源
Seminars in Immunopathology | 2020年 / 42卷
关键词
Asthma; Allergy; Genetics; Epigenetics; Interaction;
D O I
暂无
中图分类号
学科分类号
摘要
In asthma and allergy genetics, a trend towards a few main topics developed over the last 2 years. First, a number of studies have been published recently which focus on overlapping and/or very specific phenotypes: within the allergy spectrum but also reaching beyond, looking for common genetic traits shared between different diseases or disease entities. Secondly, an urgently needed focus has been put on asthma and allergy genetics in populations genetically different from European ancestry. This acknowledges that the majority of new asthma patients today are not white and asthma is a truly worldwide disease. In epigenetics, recent years have seen several large-scale epigenome-wide association studies (EWAS) being published and a further focus was on the interaction between the environment and epigenetic signatures. And finally, the major trends in current asthma and allergy genetics and epigenetics comes from the field of pharmacogenetics, where it is necessary to understand the susceptibility for and mechanisms of current asthma and allergy therapies while at the same time, we need to have scientific answers to the recent availability of novel drugs that hold the promise for a more individualized therapy.
引用
收藏
页码:43 / 60
页数:17
相关论文
共 2089 条
  • [61] Alves AC(2019)Epigenetic age acceleration is associated with allergy and asthma in children in Project Viva J Allergy Clin Immunol 143 2263-164
  • [62] Linneberg A(2009)Pharmacogenetics of beta(2)-agonists in children J Allergy Clin Immunol 124 1195-1046
  • [63] Curtin JA(2018)The use of pharmacogenomics, epigenomics, and transcriptomics to improve childhood asthma management: where do we stand? Pediatr Pulmonol 53 836-54
  • [64] Warrington NM(2019)Genomic predictors of asthma phenotypes and treatment response Front Pediatr 7 6-1610
  • [65] Standl M(2017)Anti-inflammatory chromatinscape suggests alternative mechanisms of glucocorticoid receptor action Immunity 47 298-10
  • [66] Kerkhof M(2008)The role of histone deacetylases in asthma and allergic diseases J Allergy Clin Immunol 121 580-89
  • [67] Jonsdottir I(2006)Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma Am J Respir Crit Care Med 174 134-3188
  • [68] Bukvic BK(2014)Passive smoking impairs histone deacetylase-2 in children with severe asthma Chest 145 305-510
  • [69] Kaakinen M(2012)Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 186 1248-E1295
  • [70] Sleimann P(2015)Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response J Allergy Clin Immunol 136 923-972